Literature DB >> 32123309

LPS-binding IgG arrests actively motile Salmonella Typhimurium in gastrointestinal mucus.

Holly A Schroeder1, Jay Newby2, Alison Schaefer1, Babu Subramani1, Alan Tubbs3, M Gregory Forest2, Ed Miao3, Samuel K Lai4,5.   

Abstract

The gastrointestinal (GI) mucosa is coated with a continuously secreted mucus layer that serves as the first line of defense against invading enteric bacteria. We have previously shown that antigen-specific immunoglobulin G (IgG) can immobilize viruses in both human airway and genital mucus secretions through multiple low-affinity bonds between the array of virion-bound IgG and mucins, thereby facilitating their rapid elimination from mucosal surfaces and preventing mucosal transmission. Nevertheless, it remains unclear whether weak IgG-mucin crosslinks could reinforce the mucus barrier against the permeation of bacteria driven by active flagella beating, or in predominantly MUC2 mucus gel. Here, we performed high-resolution multiple particle tracking to capture the real-time motion of hundreds of individual fluorescent Salmonella Typhimurium in fresh, undiluted GI mucus from Rag1-/- mice, and analyzed the motion using a hidden Markov model framework. In contrast to control IgG, the addition of anti-lipopolysaccharide IgG to GI mucus markedly reduced the progressive motility of Salmonella by lowering the swim speed and retaining individual bacteria in an undirected motion state. Effective crosslinking of Salmonella to mucins was dependent on Fc N-glycans. Our findings implicate IgG-mucin crosslinking as a broadly conserved function that reduces mucous penetration of both bacterial and viral pathogens.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32123309     DOI: 10.1038/s41385-020-0267-9

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  29 in total

1.  Diffusion of macromolecules and virus-like particles in human cervical mucus.

Authors:  S S Olmsted; J L Padgett; A I Yudin; K J Whaley; T R Moench; R A Cone
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

Review 2.  Immunoglobulin secretion in the airways.

Authors:  R P Daniele
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

Review 3.  Salmonella pathogenicity island 1(SPI-1) at work.

Authors:  Fengxia Que; Shuyan Wu; Rui Huang
Journal:  Curr Microbiol       Date:  2013-01-31       Impact factor: 2.188

4.  IgG and IgA content of vaginal fluid during the menstrual cycle.

Authors:  S J Usala; F O Usala; R Haciski; J A Holt; G F Schumacher
Journal:  J Reprod Med       Date:  1989-04       Impact factor: 0.142

Review 5.  Salmonellae interactions with host processes.

Authors:  Doris L LaRock; Anu Chaudhary; Samuel I Miller
Journal:  Nat Rev Microbiol       Date:  2015-03-09       Impact factor: 60.633

6.  Antibody diffusion in human cervical mucus.

Authors:  W M Saltzman; M L Radomsky; K J Whaley; R A Cone
Journal:  Biophys J       Date:  1994-02       Impact factor: 4.033

Review 7.  Role of mucus layers in gut infection and inflammation.

Authors:  Gunnar C Hansson
Journal:  Curr Opin Microbiol       Date:  2011-12-14       Impact factor: 7.934

8.  The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis.

Authors:  Maryam Zarepour; Kirandeep Bhullar; Marinieve Montero; Caixia Ma; Tina Huang; Anna Velcich; Lijun Xia; Bruce A Vallance
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

9.  Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus.

Authors:  Timothy Wessler; Alex Chen; Scott A McKinley; Richard Cone; Gregory Forest; Samuel K Lai
Journal:  ACS Infect Dis       Date:  2015-10-17       Impact factor: 5.084

Review 10.  The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system.

Authors:  Thaher Pelaseyed; Joakim H Bergström; Jenny K Gustafsson; Anna Ermund; George M H Birchenough; André Schütte; Sjoerd van der Post; Frida Svensson; Ana M Rodríguez-Piñeiro; Elisabeth E L Nyström; Catharina Wising; Malin E V Johansson; Gunnar C Hansson
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

View more
  7 in total

1.  Moniezia benedeni Infection Restrain IgA+, IgG+, and IgM+ Cells Residence in Sheep (Ovis aries) Small Intestine.

Authors:  Luo-Xia Han; Wan-Ling Yao; Jing Pan; Bao-Shan Wang; Wan-Hong He; Xi-Ping Fan; Wen-Hui Wang; Wang-Dong Zhang
Journal:  Front Vet Sci       Date:  2022-04-28

Review 2.  Flagella at the Host-Microbe Interface: Key Functions Intersect With Redundant Responses.

Authors:  Douglas T Akahoshi; Charles L Bevins
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 8.786

3.  Modeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection.

Authors:  Alexander Chen; Timothy Wessler; Katherine Daftari; Kameryn Hinton; Richard C Boucher; Raymond Pickles; Ronit Freeman; Samuel K Lai; M Gregory Forest
Journal:  Biophys J       Date:  2022-04-02       Impact factor: 3.699

Review 4.  The biophysical principles underpinning muco-trapping functions of antibodies.

Authors:  Alison Schaefer; Samuel K Lai
Journal:  Hum Vaccin Immunother       Date:  2021-07-27       Impact factor: 4.526

Review 5.  Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing.

Authors:  Kevin J Whaley; Larry Zeitlin
Journal:  Hum Vaccin Immunother       Date:  2021-07-14       Impact factor: 4.526

Review 6.  Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†.

Authors:  Deborah J Anderson; Joseph A Politch; Richard A Cone; Larry Zeitlin; Samuel K Lai; Philip J Santangelo; Thomas R Moench; Kevin J Whaley
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.161

Review 7.  Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy.

Authors:  Carlos Cruz-Teran; Karthik Tiruthani; Morgan McSweeney; Alice Ma; Raymond Pickles; Samuel K Lai
Journal:  Adv Drug Deliv Rev       Date:  2020-12-09       Impact factor: 17.873

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.